Log In
BCIQ
Print this Print this
 

PF-04518600, PF-8600

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
Description mAb against tumor necrosis factor (TNF) receptor superfamily member 4 (OX40; TNFRSF4; CD134)
Molecular Target Tumor necrosis factor (TNF) receptor superfamily member 4 (OX40) (TNFRSF4) (CD134)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today